Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/1999
10/06/1999EP0946519A1 Benzamide derivatives having a vasopressin antagonistic activity
10/06/1999EP0946512A1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
10/06/1999EP0946503A1 Nitromethylthiobenzene derivatives as inhibitors of aldose reductase
10/06/1999EP0946495A1 Phenyl acetamides as spla2 inhibitors
10/06/1999EP0946196A1 Method for treating symptoms of diabetes
10/06/1999EP0946189A1 Use of cntf (ciliary neurotrophic factor) receptor activators for the treatment of obesity
10/06/1999EP0946170A1 Inhibition of protein glycation and prevention of vasculopathy
10/06/1999CN1230989A Embryonic or stem-like cell lines produced by cross species nuclear transplantation
10/06/1999CN1230966A Use of leptin antagonists for treating insulin resistance in type II diabetes
10/06/1999CN1230892A Use of proteins as agents against autoimmune diseases
10/06/1999CN1230891A Lectin compositions and uses thereof
10/06/1999CN1230407A Method and compositions for treatment and prevention of tumors, tumor-related disorders and cachexia
10/05/1999US5962707 19-nor-vitamin D3 compounds with calcemic activity
10/05/1999US5962509 Dithiolylidene acetamide derivatives
10/05/1999US5962497 A 3,4-diphenyl substituted chroman compound
10/05/1999US5962495 Estrogen sensitive diseases; breast cancer; prostate tumors
10/05/1999US5962479 Psychological and nervous sytem disorders
10/05/1999US5962475 Osteoporosis, restenosis, breast cancer
10/05/1999US5962470 Heterocyclic compounds having anti-diabetic activity and their use
10/05/1999US5962455 Eating disorders, cardiovascular disorders, hypotensive agents
10/05/1999US5962411 Human growth hormone variants and methods of administering same
10/05/1999US5962049 Boron carbohydrate complexes and uses thereof
10/05/1999US5961981 Biologically-active compositions extracted from dictyotales plant family
09/1999
09/30/1999WO1999049027A1 Methods for prevention and treatment of cancer
09/30/1999WO1999048888A1 Imidazolone anorectic agents: ii. phenyl derivatives
09/30/1999WO1999048887A1 Imidazolone anorectic agents: iii. heteroaryl derivatives
09/30/1999WO1999048873A1 Imidazolone anorectic agents: i. acyclic derivatives
09/30/1999WO1999048488A2 Methods for decreasing beta amyloid protein
09/30/1999WO1999042465A3 Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation
09/30/1999WO1999041411A3 Method for diagnosis and treatment of disorders of carbohydrate metabolism
09/30/1999WO1999040904A3 Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the treatment of hyperglycemia
09/30/1999WO1999038518A3 Synergistic mixtures of garlic and lycopene for preventing ldl oxidation
09/30/1999WO1999037167A3 Process of improving the stability of vitamin d in a nutritional product containing hydrolyzed protein and product produced thereby
09/30/1999WO1999029308A3 Method for combating obesity
09/30/1999CA2325588A1 Imidazolone anorectic agents: i. acyclic derivatives
09/30/1999CA2325587A1 Imidazolone anorectic agents: ii. phenyl derivatives
09/30/1999CA2325472A1 Imidazolone anorectic agents: iii. heteroaryl derivatives
09/30/1999CA2324999A1 Methods for decreasing .beta.-amyloid protein
09/30/1999CA2323782A1 Methods for prevention and treatment of cancer
09/29/1999EP0944721A1 Adipocyte-specific differentiation-related protein
09/29/1999EP0944648A1 Glp-1 derivatives
09/29/1999EP0944630A1 Xanthines and their therapeutic use
09/29/1999EP0944626A1 Tropane derivatives and method for their synthesis
09/29/1999EP0944611A1 Dimesylate salts of neuropeptide y ligands
09/29/1999EP0944602A1 Apo b-secretion/mtp inhibitory amides
09/29/1999EP0944592A1 Vitamin d3 derivatives
09/29/1999EP0944396A1 Compositions and methods for enhancing intestinal function
09/29/1999CN1230222A PTX-sensitive G proteins, prodn. and use thereof
09/29/1999CN1230196A Modified aminoacids, pharmaceuticals containing these compounds and method for their prodn.
09/29/1999CN1230186A Pyrazolopyridine compound and pharmaceutical use thereof
09/29/1999CN1230119A Methods for enhancing lean tissue mass and bone mineral content and compsns therefor
09/29/1999CN1230114A Novel treatment of leptine resistance
09/29/1999CN1230110A Cell adhesion inhibitors
09/29/1999CN1229655A Medicinal decoction for treating diabets mellitus
09/29/1999CN1045294C Method for prepn. of indole derivatives
09/28/1999US5959123 Reacating substituted amino acid with 3-amino-4-substituted-azetidine-2-one compound to form 3, 4-disubstituted-azetidine-2-one compound; useful for treating muscular dystrophy, arthritis, viral and parasitic infections
09/28/1999US5959103 Naphthofluorene compounds, intermediates, compositions, and methods
09/28/1999US5958969 Osteoporosis
09/28/1999US5958954 2,2-dialkyl-4-aryl-substituted benzopyran and benzothiopyran derivatives
09/28/1999US5958953 Substituted indazole derivatives
09/28/1999US5958943 A!-anellated pyrrole derivatives and their use in pharmacology
09/28/1999US5958917 Benzofluorene compounds, intermediates, compositions, and methods
09/28/1999US5958913 Administering saturated sterol fatty acid ester
09/28/1999US5958908 Sodium alendronate preparation for local administration
09/28/1999US5958885 Peptide and formulations thereof inhibiting elevations of triglyceride levels in blood
09/28/1999US5958709 Processes for identifying compounds that bind to the human Y4 receptor
09/28/1999US5958683 Screening method using the RZR receptor family
09/28/1999US5958426 Sphingolipids and a process thereto
09/28/1999US5958421 Cosmetic or pharmaceutical composition containing an andiroba extract
09/28/1999US5958417 Herbal combinations
09/28/1999US5958401 Method of using IL-11 for treating psoriasis
09/28/1999US5958400 Isolated polypeptide comprising specified amino acid sequence
09/28/1999CA2187803C Methods of treating disease using sertoli cells and allografts or xenografts
09/23/1999WO1999047565A1 Anti-inositolphosphoglycan monoclonal antibodies
09/23/1999WO1999047564A1 Fas-associated polypeptides
09/23/1999WO1999047549A1 PIPERAZINES AS INHIBITORS OF FRUCTOSE-1,6-BISPHOSPHATASE (FBPase)
09/23/1999WO1999047547A1 Cinnamic acid derivatives having cell adhesion modulating activity
09/23/1999WO1999047524A1 Novel heterocyclic compounds
09/23/1999WO1999047517A1 Novel heterocyclic compounds
09/23/1999WO1999047508A1 Benzenesulfonamide-derivatives and their use as medicaments
09/23/1999WO1999047160A1 Stabilized aqueous peptide solutions
09/23/1999WO1999047154A1 Dipeptide caspase inhibitors and the use thereof
09/23/1999WO1999047148A1 Composition from ginkgo biloba leaves, preparation and uses
09/23/1999WO1999047138A1 Statin-matrix metalloproteinase inhibitor combinations
09/23/1999WO1999047128A1 Biphasic controlled release delivery system for high solubility pharmaceuticals and method
09/23/1999WO1999047125A1 Controlled release oral tablet having a unitary core
09/23/1999WO1999047123A1 Pharmaceutical composition containing a statin and aspirin
09/23/1999WO1999033859A9 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
09/23/1999CA2323783A1 Benzenesulfonamide-derivatives and their use as medicaments
09/23/1999CA2323439A1 Dipeptide caspase inhibitors and the use thereof
09/23/1999CA2321113A1 Anti-inositolphosphoglycan monoclonal antibodies
09/23/1999CA2309588A1 Statin-matrix metalloproteinase inhibitor combinations
09/23/1999CA2289621A1 Piperazines as inhibitors of fructose-1,6-bisphosphatase (fbpase)
09/23/1999CA2249662A1 Novel compounds
09/22/1999EP0943003A1 Insulin-like growth factor i (igf-i) expression system and methods of use
09/22/1999EP0942933A1 Human kdel receptor
09/22/1999EP0942915A1 Pharmaceutical formulations
09/22/1999EP0942896A1 Substituted phenols and thiophenols useful as antioxidant agents
09/22/1999EP0942755A2 Treatment of diabetes with transcription factor gene
09/22/1999EP0942741A1 Lectin compositions and uses thereof